Sudeep Pharma Share Price, IPO Listing LIVE: Sudeep Pharma is set to finalise its share allotment today, after three days of subscription. The Rs 895 crore initial public offering (IPO) was between November 21-25.
Sudeep Pharma IPO: Subscription recap
On the final day of bidding, the IPO saw applications for more than 99 crore shares, far more than the 1.05 crore shares available. This resulted in an overall subscription of 93.71 times, according to data from the National Stock Exchange (NSE).
Retail investors subscribed their portion 15.65 times, while the Non-Institutional Investors (NIIs), who typically include high-net-worth individuals, submitted bids worth 116.72 times their quota. The Qualified Institutional Buyers (QIBs) received a subscription of 213.08 times.
| Sudeep Pharma IPO | Key Details |
| Price bnfnd | Rs 563-593 per share |
| Subscription | 93.71 times |
| GMP | 14.67% |
| IPO Allotment date | November 26 |
| Listing date | November 28 |
Sudeep Pharma IPO: Grey market trend
Ahead of the listing, Sudeep Pharma’s unlisted shares have been actively traded in the grey market. The stock is currently quoted around Rs 680, which indicates a grey market premium (GMP) of about 14.67% over the IPO’s upper price band of Rs 593.
What Sudeep Pharma does
The company is involved in the manufacturing of pharmaceutical excipients and speciality ingredients, which are essential components used in medicines. Furthermore, it operates six manufacturing plants. It produces mineral-based ingredients such as calcium, magnesium, iron, zinc, sodium and potassium.
Sudeep Pharma IPO Allotment Status Live: Follow Live Coverage on Sudeep Pharma IPO GMP, Allotment Status, Grey Market Premium, Listing Date, Review and More
Sudeep Pharma IPO Allotment Status, GMP Live: Checking on the NSE website
The National Stock Exchange also allows applicants to track their IPO applications.
Visit the section that displays bid details for equity and SME offers.
After selecting Sudeep Pharma from the available issues, submit the required details such as your PAN and application number. The page will then show whether the shares have been allotted to you.
Sudeep Pharma IPO Allotment Status, GMP Live: IPO GMP trending higher
The GMP for the Sudeep Pharma IPO is up 14%. This indicates that the issue may list at a premium. However, readers must remember that the GMP is an unofficial metric and the actual listing price could be very different.
Sudeep Pharma IPO Allotment Status, GMP Live: Checking through the BSE website
Investors can verify their allotment status directly on the official BSE portal.
Once you open the page meant for IPO allotments, select the option for equity issues and look for Sudeep Pharma in the drop-down list.
You can proceed by entering either your application number or your Permanent Account Number (PAN).
After confirming the captcha, the system displays the status linked to your application.
Sudeep Pharma IPO Allotment Status, GMP Live: Where the IPO money will be used
A part of the public issue consists of new shares issued by the company. The funds raised from this portion will be used mainly for capital expenditure. This includes the purchase of new machinery for the production line at the company’s Nandesari Facility 1 in Gujarat. A portion of the proceeds will also be directed towards general corporate requirements.